DropXcell

DropXcell

United StatesUnited States
Pre-seedFounded 2024
AI/MLBio Tech/Life SciencesB2B0-10 employees
First-Time FounderFirst-Time FounderAsian/Pacific FounderAsian/Pacific FounderExited FounderExited Founder

About

DropXcell enables more effective and lower risk drug discovery by quantifying millions of antibodies’ function in key biological pathways.

Traction & Metrics

Financial

$125K

ARR

Fundraising

$2M

Current Raise

375000%

Committed

$210K

Previous Round

Team

Tony

Tony

CSO

Pavel

Pavel

CTO

Luke

Luke

CEO

Products

Quantify function in disease for millions of antibodies

Design and optimize antibody libraries with AI for high throughput screening

Help early stage therapeutic companies find lead antibody candidates or tool molecules for low upfront cost

Click to read more

Updates

Presented at Stanford Alumni Plug and Play pitch event

Presented at Stanford Alumni Plug and Play pitch event

37 handpicked Stanford companies, hundreds in attendance

Accepted into AI launchpad program

Accepted into AI launchpad program

In the launchpad, TheAgentic will build our AI backend for therapeutic discovery at no risk and no upfront cost

Pitched at Plug and Play

Pitched at Plug and Play

Luke pitched to over 500 people at Plug and Play Tech Center as one of 10 invited speakers

Won $25k at Pitch Competition

Won $25k at Pitch Competition

Presented DropXcell for hundreds and an investor panel to win the $25k prize!

Want to connect with this startup?

Sign up for First Glance to follow startups, save favorites, and connect with founders.

Or get the app for a better experience